SCHEMBL21391872

SCHEMBL21391872

CCCCOc1ccccc1OCCCC(C)C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.56
CYP2C19 P33261 3/20 0.56
CYP2C9 P11712 2/20 0.56
HTT P42858 1/20 0.46
PPIA P62937 1/20 0.45
L3MBTL1 Q9Y468 3/20 0.44
LTA4H P09960 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
CYP19A1 P11511 1/20 0.44
CYP2D6 P10635 1/20 0.43
MAPT P10636 2/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
NR1I2 O75469 1/20 0.42
LMNA P02545 1/20 0.42
CHRM2 P08172 1/20 0.42
CYP3A4 P08684 1/20 0.42
ADRA2A P08913 1/20 0.42
OPRK1 P41145 1/20 0.42
HTR2B P41595 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21391871 0.94 CYP1A2 (0.50) CYP1A2CYP2C19CYP2C9HTTPPIA
1-Isopentoxy-2-Butoxybenzene SCHEMBL2848360 0.92 CYP1A2 (0.56) CYP1A2CYP2C19CYP2C9HTTL3MBTL1
SCHEMBL19806810 0.92 HTT (0.51) CYP1A2CYP2C19CYP2C9HTTPPIA
1,2-Dibutoxybenzene SCHEMBL29428927 0.85 CYP1A2 (0.72) CYP1A2CYP2C19CYP2C9L3MBTL1LTA4H
1,2-Dibutoxybenzene SCHEMBL1226749 0.85 CYP1A2 (0.72) CYP1A2CYP2C19CYP2C9L3MBTL1LTA4H
SCHEMBL7931093 0.85 CYP1A2 (0.56) CYP1A2CYP2C19CYP2C9L3MBTL1LTA4H
1,2-Dibutoxybenzene SCHEMBL6236324 0.83 CYP1A2 (0.69) CYP1A2CYP2C19CYP2C9L3MBTL1LTA4H
SCHEMBL20845612 0.83 HTT (0.49) CYP1A2CYP2C19CYP2C9HTTPPIA
SCHEMBL27555724 0.82 HTT (0.56) CYP1A2CYP2C19CYP2C9HTTL3MBTL1
1-Propoxy-2-Butoxybenzene SCHEMBL2846696 0.81 CYP1A2 (0.67) CYP1A2CYP2C19CYP2C9L3MBTL1LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11034720-B2 Thiol-yne based peptide stapling and uses thereof UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2021-06-15 US disclosed
US-20190292218-A1 THIOL-YNE BASED PEPTIDE STAPLING AND USES THEREOF UNIVERSITY OF UTAH 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292218-A1 THIOL-YNE BASED PEPTIDE STAPLING AND USES THEREOF IAPP, TP53, GLP1R CYP1A2 4369/4885CYP2C19 4281/4885CYP2C9 4111/4885
US-11034720-B2 Thiol-yne based peptide stapling and uses thereof IAPP, TP53, GLP1R CYP1A2 4369/4885CYP2C19 4281/4885CYP2C9 4111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.